Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Malgorzata Gorniak"'
Autor:
Jessie Zhao, Tiffany Khong, Malgorzata Gorniak, Abir Khaled, Zac McDonald, John Reynolds, Sridurga Mithraprabhu, Nicholas Bingham, Suehli Lim, Daniel Wong, Anna Johnston, Olga Motorna, Nicholas Murphy, Hang Quach, Liqiang Yang, Andrew Spencer
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/3a455da3183447bea2d9a2974dfd5e9e
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Measurable residual disease (MRD) is being recognised as an optimal method for assessing depth of response, identifying higher risk of relapse, and guiding response-based treatment paradigms for multiple myeloma (MM). Although MRD negativity is incre
Externí odkaz:
https://doaj.org/article/1085de1ead3940ab9874a7928818bdd5
Autor:
Anna Kalff, Tiffany Khong, Meaghan Wall, Malgorzata Gorniak, Sridurga Mithraprabhu, Lynda J. Campbell, Andrew Spencer
Publikováno v:
Haematologica, Vol 100, Iss 2 (2015)
Externí odkaz:
https://doaj.org/article/67319f7429e24418a551b24e21e891ee
Autor:
Malgorzata Gorniak, Johanna Petzoldt, Kristina Schäfer, Nele Wessels, Matthias Rudolf, Bärbel Bergmann
Publikováno v:
Zeitschrift für Hochschulentwicklung (2011)
Langjährige Erfahrungen und Prüfungsergebnisse zeigen, dass die Aneignung und die Anwendung methodischen Wissens zur Versuchsplanung von vielen Studierenden der Psychologie als sehr schwierig erlebt werden. Die Anwendung von E-Learning-Komponenten
Externí odkaz:
https://doaj.org/article/83edcafbd5314cddbdd198d0b984e747
Autor:
Paul U Cameron, Penelope Jones, Malgorzata Gorniak, Kate Dunster, Eldho Paul, Sharon Lewin, Ian Woolley, Denis Spelman
Publikováno v:
PLoS ONE, Vol 6, Iss 8, p e23164 (2011)
Asplenic patients have a lifelong risk of overwhelming post-splenectomy infection and have been reported to have low numbers of peripheral blood IgM memory B cells. The clinical value of quantitation of memory B cells as an indicator of splenic abnor
Externí odkaz:
https://doaj.org/article/19ba4038206b439bb691e4776624da62
Publikováno v:
Neurochemical Research
Tweety-homolog 1 protein (Ttyh1) is abundantly expressed in neurons in the healthy brain, and its expression is induced under pathological conditions. In hippocampal neurons in vitro, Ttyh1 was implicated in the regulation of primary neuron morpholog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa8c076d84e207f6677c661edb8dd534
https://doi.org/10.1007/s11064-021-03374-2
https://doi.org/10.1007/s11064-021-03374-2
Autor:
Malgorzata Gorniak, Andrew Spencer, Anna Kalff, Jenny Muirhead, David Kliman, Patricia Walker, Tongted Das, Joanne L. C. Tan
Publikováno v:
Bone Marrow Transplantation. 56:1116-1125
Prognostic factors for multiple myeloma (MM) after allogeneic haemopoietic stem cell transplantation (alloHSCT) are poorly characterised. Two potential factors include minimal residual disease (MRD) and CD3+ donor-specific chimerism. We retrospective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89840b1746901cd6ee7a6c6e33bd4c1e
https://doi.org/10.1038/s41409-020-01148-y
https://doi.org/10.1038/s41409-020-01148-y
Autor:
Christian J. Hoffmann, Diede W. M. Broekaart, Melanie T. C. Kuffner, Janet Lips, Antonino Asaro, Majed Kikhia, Philipp Boehm-Sturm, Monika Dopatka, Ulrich Dirnagl, Eleonora Aronica, Christoph Harms, Anna R. Malik, Susanne Mueller, Thomas E. Willnow, Malgorzata Gorniak‐Walas
Publikováno v:
Glia 68(6), 1304-1316 (2020). doi:10.1002/glia.23778
GLIA, 68(6), 1304-1316. John Wiley and Sons Inc.
Glia, 68(6), 1304-1316. John Wiley and Sons Inc.
GLIA, 68(6), 1304-1316. John Wiley and Sons Inc.
Glia, 68(6), 1304-1316. John Wiley and Sons Inc.
SorCS2 is an intracellular sorting receptor of the VPS10P domain receptor gene family recently implicated in oxidative stress response. Here, we interrogated the relevance of stress-related activities of SorCS2 in the brain by exploring its role in i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52c38756a939ab0f87dfa7138d287e22
https://doi.org/10.1002/glia.23778
https://doi.org/10.1002/glia.23778
Publikováno v:
Frontiers in oncology. 12
Measurable residual disease (MRD) is being recognised as an optimal method for assessing depth of response, identifying higher risk of relapse, and guiding response-based treatment paradigms for multiple myeloma (MM). Although MRD negativity is incre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c3b3cabf10dccccb82cae7ce1a3c552
https://pubmed.ncbi.nlm.nih.gov/35664737
https://pubmed.ncbi.nlm.nih.gov/35664737
Autor:
Kah Teong Soh, Neil Came, Gregory E. Otteson, Dragan Jevremovic, Min Shi, Horatiu Olteanu, Alessandro Natoni, Anand Lagoo, Edward Theakston, Jón Þórir Óskarsson, Malgorzata Gorniak, George Grigoriadis, Maria Arroz, Matthew Fletcher, Pei Lin, Peter Ludwig, Prashant Tembhare, Reda Matuzeviciene, Mantas Radzevicius, Sigi Kay, Weina Chen, Carina Cabrita, Paul K. Wallace
Publikováno v:
Cytometry B Clin Cytom
BACKGROUND: Multiple myeloma (MM) measurable residual disease (MRD) evaluated by flow cytometry is a surrogate for progression-free and overall survival in clinical trials. However, analysis and reporting between centers lack uniformity. We designed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39f09b9238e8f3ce96d88af83cb2b71d
https://pubmed.ncbi.nlm.nih.gov/35005838
https://pubmed.ncbi.nlm.nih.gov/35005838